# PGL2001 Proof of Concept Study in Symptomatic Endometriosis

> **NCT01631981** · PHASE2 · COMPLETED · sponsor: **PregLem SA** · enrollment: 162 (actual)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** PGL2001 + Primolut-Nor 5
- **DRUG:** Placebo + Primolut-Nor 5

## Key facts

- **NCT ID:** NCT01631981
- **Lead sponsor:** PregLem SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2013-10
- **Final completion:** 2014-05
- **Target enrollment:** 162 (ACTUAL)
- **Last updated:** 2014-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01631981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01631981, "PGL2001 Proof of Concept Study in Symptomatic Endometriosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01631981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*